Suppr超能文献

在接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死中,休克指数比心源性休克更敏感。

Shock Index More Sensitive Than Cardiogenic Shock in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

作者信息

Hemradj Veemal V, Ottervanger Jan Paul, de Boer Menko Jan, Suryapranata Harry

机构信息

Department of Cardiology, Isala Heart Centre.

出版信息

Circ J. 2017 Jan 25;81(2):199-205. doi: 10.1253/circj.CJ-16-0616. Epub 2016 Dec 16.

Abstract

BACKGROUND

Cardiogenic shock (CS) is a strong predictor of mortality in patients with ST-elevation myocardial infarction (STEMI), but there is evidence that shock index (SI), taking into account both blood pressure and heart rate, is a more sensitive and powerful predictor. We investigated the independent impact of SI and CS on 30-day and 1-year mortality in patients with STEMI, treated by primary percutaneous coronary intervention (PCI).

METHODS AND RESULTS

In 7,412 consecutive patients with STEMI treated with primary PCI, the predictive value of either SI or CS on 1-year mortality was assessed. Best cut-off value of SI, determined using receiver operating characteristic (ROC) curve, was 0.7, with an ROC AUC of 0.66 (95% CI: 0.65-0.67), compared with an ROC AUC of 0.60 (95% CI: 0.59-0.61) for CS (P<0.001). At admission, 387 patients (5.2%) had CS and 1,567 patients (21.1%) had SI ≥0.7. The adjusted hazard ratio of mortality in patients with SI ≥0.7 and in CS patients was, respectively, 3.3 (95% CI: 2.4-4.6) and 3.1 (95% CI: 2.1-4.6) after 30 days, and 2.3 (95% CI: 1.8-2.9) and 3.1 (95% CI: 2.2-4.2) after 1 year.

CONCLUSIONS

SI identifies more patients with increased risk of mortality, and seems to be a more sensitive prognostic predictor than CS in patients with STEMI treated by primary PCI.

摘要

背景

心源性休克(CS)是ST段抬高型心肌梗死(STEMI)患者死亡率的强有力预测指标,但有证据表明,同时考虑血压和心率的休克指数(SI)是更敏感且有力的预测指标。我们研究了SI和CS对接受直接经皮冠状动脉介入治疗(PCI)的STEMI患者30天和1年死亡率的独立影响。

方法与结果

在7412例连续接受直接PCI治疗的STEMI患者中,评估了SI或CS对1年死亡率的预测价值。使用受试者工作特征(ROC)曲线确定的SI最佳截断值为0.7,ROC曲线下面积(AUC)为0.66(95%CI:0.65-0.67),而CS的ROC AUC为0.60(95%CI:0.59-0.61)(P<0.001)。入院时,387例患者(5.2%)发生CS,1567例患者(21.1%)的SI≥0.7。SI≥0.7的患者和CS患者死亡率的校正风险比在30天后分别为3.3(95%CI:2.4-4.6)和3.1(95%CI:2.1-4.6),1年后分别为2.3(95%CI:1.8-2.9)和3.1(95%CI:2.2-4.2)。

结论

SI可识别出更多死亡风险增加的患者,在接受直接PCI治疗的STEMI患者中,SI似乎是比CS更敏感的预后预测指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验